Home > Boards > US OTC > Biotechs > Ampio Pharmaceuticals, Inc (AMPE)

Interesting look from Monthly perspective. As you noted,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Citrati Member Profile
 
Followed By 311
Posts 13,937
Boards Moderated 0
Alias Born 01/02/10
160x600 placeholder
Ampio Pharmaceuticals Ongoing Phase I Clinical Trial for Inhalation Treatment of COVID-19 with Ampion is 55% Enrolled PR Newswire (US) - 1/14/2021 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2021 4:59:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2021 4:58:29 PM
Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients PR Newswire (US) - 1/4/2021 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/29/2020 4:18:32 PM
Ampio Receives feedback from the FDA on Ampio's Proposed Modifications to the special protocol assessment for Ampion treatmen... PR Newswire (US) - 12/29/2020 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 6:41:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 6:39:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 6:37:51 PM
Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion PR Newswire (US) - 12/17/2020 9:15:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2020 4:02:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2020 2:25:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/15/2020 2:24:03 PM
Ampio Enters into Collaborative Research Agreements to Explore Additional Clinical Indications for its Immunomodulatory Drug,... PR Newswire (US) - 12/10/2020 9:15:00 AM
Ampio Pharmaceuticals, Inc. to Host its Annual Meeting on December 12, 2020 PR Newswire (US) - 12/8/2020 9:15:00 AM
Ampio's Phase I Study For Inhaled Ampion Advances To Completing Enrollment Of COVID-19 Patients With Respiratory Distress PR Newswire (US) - 12/2/2020 9:15:00 AM
Ampio Updates Regulatory and Clinical Trial Events PR Newswire (US) - 11/25/2020 9:15:00 AM
Ampio's Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress PR Newswire (US) - 11/17/2020 9:15:00 AM
Ampio's Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 Patients With Respiratory Distress PR Newswire (US) - 11/10/2020 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:02:00 PM
Ampio Pharmaceuticals, Inc. Provides Business Update and Reports Third Quarter 2020 Financial Results PR Newswire (US) - 11/5/2020 3:45:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/3/2020 9:32:51 AM
Ampio Pharmaceuticals, Inc. to Host Conference Call on November 5th PR Newswire (US) - 11/2/2020 9:15:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 10/30/2020 11:21:24 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/30/2020 11:13:06 AM
Citrati   Friday, 11/06/20 08:59:01 AM
Re: 0210 post# 898
Post # of 1107 
Interesting look from Monthly perspective. As you noted, Daily chart needs more strength which the hourly still has room to provide before resting. We shall see.
Price remaining above the +stacked 4 and 8ema's and maintaining their up angle is important for the long term.

Green Trades



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences